BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29436186)

  • 1. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
    Lee J; Ahn SS; Chang JH; Suh CO
    Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.
    Dincoglan F; Beyzadeoglu M; Sager O; Demiral S; Gamsiz H; Uysal B; Ebruli C; Akin M; Oysul K; Sirin S; Dirican B
    Tumori; 2015; 101(2):179-84. PubMed ID: 25791534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse.
    Tong E; Horsley P; Wheeler H; Wong M; Venkatesha V; Chan J; Kastelan M; Back M
    J Neurooncol; 2024 May; 168(1):69-76. PubMed ID: 38551747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-irradiation with radiosurgery for recurrent glioblastoma multiforme.
    Torok JA; Wegner RE; Mintz AH; Heron DE; Burton SA
    Technol Cancer Res Treat; 2011 Jun; 10(3):253-8. PubMed ID: 21517131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors.
    Lee J; Cho J; Chang JH; Suh CO
    Yonsei Med J; 2016 Jul; 57(4):824-30. PubMed ID: 27189273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience.
    Ciammella P; Podgornii A; Galeandro M; D'Abbiero N; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
    Radiat Oncol; 2013 Sep; 8():222. PubMed ID: 24066926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
    Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
    Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
    Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
    Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of salvage treatment for recurrent glioblastoma.
    Kim HR; Kim KH; Kong DS; Seol HJ; Nam DH; Lim DH; Lee JI
    J Clin Neurosci; 2015 Mar; 22(3):468-73. PubMed ID: 25595963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.
    Reddy K; Damek D; Gaspar LE; Ney D; Waziri A; Lillehei K; Stuhr K; Kavanagh BD; Chen C
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):655-60. PubMed ID: 22483738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection.
    Elliott RE; Parker EC; Rush SC; Kalhorn SP; Moshel YA; Narayana A; Donahue B; Golfinos JG
    World Neurosurg; 2011; 76(1-2):128-40; discussion 61-2. PubMed ID: 21839964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated stereotactic reirradiation for recurrent glioblastoma.
    Yazici G; Cengiz M; Ozyigit G; Eren G; Yildiz F; Akyol F; Gurkaynak M; Zorlu F
    J Neurooncol; 2014 Oct; 120(1):117-23. PubMed ID: 25012955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
    Combs SE; Widmer V; Thilmann C; Hof H; Debus J; Schulz-Ertner D
    Cancer; 2005 Nov; 104(10):2168-73. PubMed ID: 16220556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?
    Fokas E; Wacker U; Gross MW; Henzel M; Encheva E; Engenhart-Cabillic R
    Strahlenther Onkol; 2009 Apr; 185(4):235-40. PubMed ID: 19370426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.
    Palmer JD; Siglin J; Yamoah K; Dan T; Champ CE; Bar-Ad V; Werner-Wasik M; Evans JJ; Kim L; Glass J; Farrell C; Andrews DW; Shi W
    J Neurooncol; 2015 Sep; 124(2):215-21. PubMed ID: 26024653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.
    Miwa K; Matsuo M; Ogawa S; Shinoda J; Yokoyama K; Yamada J; Yano H; Iwama T
    Radiat Oncol; 2014 Aug; 9():181. PubMed ID: 25123357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post Hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100A™ system versus best physician's choice chemotherapy.
    Kanner AA; Wong ET; Villano JL; Ram Z;
    Semin Oncol; 2014 Oct; 41 Suppl 6():S25-34. PubMed ID: 25213871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.